Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 8/20 | 0.56 |
| ▸ | GBA2 | Q9HCG7 | 13/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | UGCG | Q16739 | 1/20 | 0.43 |
| ▸ | GUSB | P08236 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8875789 | 1.00 | GBA1 (0.56) | GBA1GBA2GAAUGCGGUSB | |
| SCHEMBL9555193 | 1.00 | GBA1 (0.56) | GBA1GBA2GAAUGCGGUSB | |
| SCHEMBL8879898 | 1.00 | GBA1 (0.56) | GBA1GBA2GAAUGCGGUSB | |
| SCHEMBL10853881 | 1.00 | GBA1 (0.56) | GBA1GBA2GAAUGCGGUSB | |
| SCHEMBL12846762 | 0.93 | GBA2 (0.54) | GBA1GBA2GAAUGCG | |
| SCHEMBL8893021 | 0.93 | GBA2 (0.54) | GBA1GBA2GAAUGCG | |
| SCHEMBL8984709 | 0.93 | GBA2 (0.54) | GBA1GBA2GAAUGCG | |
| Palmitamide SCHEMBL1072216 | 0.91 | GBA1 (0.49) | GBA1GBA2GAA | |
| SCHEMBL12155329 | 0.86 | GBA1 (0.51) | GBA1GBA2GAA | |
| SCHEMBL8894199 | 0.86 | GBA1 (0.51) | GBA1GBA2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111229189-B | Self-assembly type amino acid derivative functionalized magnetic-carbon nanotube composite material and preparation method and application thereof | 天津大学 | 2022-02-08 | — | — | CN | claimed |
| CN-111229189-A | Self-assembly type amino acid derivative functionalized magnetic-carbon nanotube composite material and preparation method and application thereof | 天津大学 | 2020-06-05 | — | — | CN | claimed |
| EP-2968108-A1 | COSMETIC COMPOSITIONS | Mary Kay, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014159238-A1 | COSMETIC COMPOSITIONS | MARY KAY INC. (US) | 2014-10-02 | — | — | WO | claimed |
| US-20140271525-A1 | COSMETIC COMPOSITIONS | MARY KAY INC. (US) | 2014-09-18 | — | — | US | claimed |
| EP-2616169-A2 | CHROMATOGRAPHY MEMBRANES FOR THE PURIFICATION OF CHIRAL COMPOUNDS | Natrix Separations Inc. (CA) | 2013-07-24 | — | — | EP | claimed |
| WO-2012037101-A2 | CHROMATOGRAPHY MEMBRANES FOR THE PURIFICATION OF CHIRAL COMPOUNDS | NATRIX SEPARATIONS INC. (CA) | 2012-03-22 | — | — | WO | claimed |
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | SYMRISE AG (DE) | 2026-03-03 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| US-20250270182-A1 | Composition Comprising an Antimicrobial Agent and an Alkyl Ketal Ester Compound | SYMRISE AG (DE) | 2025-08-28 | — | — | US | disclosed |
| US-20250255833-A1 | Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants | SYMRISE AG (DE) | 2025-08-14 | — | — | US | disclosed |
| US-12350357-B2 | Active agents for skin and hair care with physicochemical modifying properties | SYMRISE AG (DE) | 2025-07-08 | — | — | US | disclosed |
| US-12303468-B2 | Compositions comprising one or more (bio)-alkanediols with antioxidants | SYMRISE AG (DE) | 2025-05-20 | — | — | US | disclosed |
| US-20110091404-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE | SYMRISE AG (DE) | 2011-04-21 | — | — | US | disclosed |
| US-20110034486-A1 | USE OF PTEROCARPANS AS ACTIVE ANTI-CELLULITE INGREDIENTS | SYMRISE GMBH & CO., KG (DE) | 2011-02-10 | — | — | US | disclosed |
| US-20100196504-A1 | SYNERGISTIC ACTIVE PREPARATIONS COMPRISING 1,2-DECANEDIOL AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2010-08-05 | — | — | US | disclosed |
| US-20090306154-A1 | SYNERGISTIC ANTI-MICROBIAL MIXTURES OF TROPOLONE (DERIVATIVES) AND SELECTED COMPOUNDS | SYMRISE GMBH & CO., KG (DE) | 2009-12-10 | — | — | US | disclosed |
| EP-0143147-B1 | PROCESS FOR THIN LAYER CHROMATOGRAPHIC SEPARATION OF ENANTIOMERS | Degussa Aktiengesellschaft (DE) | 1987-09-09 | — | — | EP | disclosed |
| US-4590167-A | CHROMATOGRAPHIC PLATE COATED WITH SILICA GEL IMPREGNATED WITH TRANSITION METAL COMPOUND AND CHIRAL SEPARATOR | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1986-05-20 | — | — | US | disclosed |
| EP-0143147-A2 | Process for thin layer chromatographic separation of enantiomers | Degussa Aktiengesellschaft (DE) | 1985-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250255833-A1 | Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants | MMP8, CXCL8, IL18 | GBA1 3042/4885GBA2 2394/4885GAA 1027/4885 |
| US-20250270182-A1 | Composition Comprising an Antimicrobial Agent and an Alkyl Ketal Ester Compound | GK, DAGLA, KAT5 | GBA1 962/4885GBA2 1350/4885GAA 345/4885 |
| US-20100196504-A1 | SYNERGISTIC ACTIVE PREPARATIONS COMPRISING 1,2-DECANEDIOL AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | DDT, CUTA, DPM1 | GBA1 1930/4885GBA2 2815/4885GAA 2929/4885 |
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | CUTA, HLA-A, OAT | GBA1 2292/4885GBA2 1240/4885GAA 464/4885 |
| US-12303468-B2 | Compositions comprising one or more (bio)-alkanediols with antioxidants | MMP8, CXCL8, IL18 | GBA1 3042/4885GBA2 2394/4885GAA 1027/4885 |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | GBA1 1989/4885GBA2 894/4885GAA 2280/4885 |
| US-20140271525-A1 | COSMETIC COMPOSITIONS | SGMS1, SGMS2, ITCH | GBA1 288/4885GBA2 410/4885GAA 1042/4885 |
| US-20090306154-A1 | SYNERGISTIC ANTI-MICROBIAL MIXTURES OF TROPOLONE (DERIVATIVES) AND SELECTED COMPOUNDS | CBR3, MTPN, UTRN | GBA1 968/4885GBA2 2033/4885GAA 926/4885 |
| US-20110034486-A1 | USE OF PTEROCARPANS AS ACTIVE ANTI-CELLULITE INGREDIENTS | FABP4, PLIN1, CPT1B | GBA1 3406/4885GBA2 3473/4885GAA 1982/4885 |
| US-20110091404-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE | CUTA, FHIT, FAM83A | GBA1 2446/4885GBA2 1219/4885GAA 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.